192 related articles for article (PubMed ID: 34798847)
1. Living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria: outcome of expanded criteria in tumor size.
Liang HR; Hsieh CE; Lin KH; Ko CJ; Hung YJ; Hsu YL; Chen YL
BMC Surg; 2021 Nov; 21(1):401. PubMed ID: 34798847
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for hepatocellular carcinoma: Korean experience.
Lee S; Ahn C; Ha T; Moon D; Choi K; Song G; Chung D; Park G; Yu Y; Choi N; Kim K; Kim K; Hwang S
J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):539-47. PubMed ID: 19727542
[TBL] [Abstract][Full Text] [Related]
3. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
Lee EC; Kim SH; Shim JR; Park SJ
Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
[TBL] [Abstract][Full Text] [Related]
5. Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria).
Llovet JM; Pavel M; Rimola J; Diaz MA; Colmenero J; Saavedra-Perez D; Fondevila C; Ayuso C; Fuster J; Ginès P; Bruix J; Garcia-Valdecasas JC
Liver Transpl; 2018 Mar; 24(3):369-379. PubMed ID: 29140601
[TBL] [Abstract][Full Text] [Related]
6. Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule - a retrospective study.
Shimamura T; Akamatsu N; Fujiyoshi M; Kawaguchi A; Morita S; Kawasaki S; Uemoto S; Kokudo N; Hasegawa K; Ohdan H; Egawa H; Furukawa H; Todo S;
Transpl Int; 2019 Apr; 32(4):356-368. PubMed ID: 30556935
[TBL] [Abstract][Full Text] [Related]
7. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
8. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
[TBL] [Abstract][Full Text] [Related]
9. Living donor liver transplantation for hepatocellular carcinoma: results of prospective patient selection by Kyushu University Criteria in 7 years.
Uchiyama H; Itoh S; Yoshizumi T; Ikegami T; Harimoto N; Soejima Y; Harada N; Morita K; Toshima T; Motomura T; Maehara Y
HPB (Oxford); 2017 Dec; 19(12):1082-1090. PubMed ID: 28888776
[TBL] [Abstract][Full Text] [Related]
10. Role of Adult Living Donor Liver Transplantation in the Treatment of Hepatocellular Carcinoma Within and Beyond Milan Criteria: A Comparative Study.
Pavel MC; Sanchez Cabus S; Crespo G; Ferrer J; Fondevila C; Fuster J; Garcia-Valdecasas JC
Transplant Proc; 2018 Jun; 50(5):1386-1395. PubMed ID: 29880361
[TBL] [Abstract][Full Text] [Related]
11. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma.
Soejima Y; Taketomi A; Yoshizumi T; Uchiyama H; Aishima S; Terashi T; Shimada M; Maehara Y
Transplantation; 2007 Apr; 83(7):893-9. PubMed ID: 17460559
[TBL] [Abstract][Full Text] [Related]
12. Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria.
Cho Y; Lee JH; Lee DH; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS
Oncotarget; 2017 Jul; 8(29):47555-47564. PubMed ID: 28548930
[TBL] [Abstract][Full Text] [Related]
13. Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria.
Alim A; Erdogan Y; Dayangac M; Yuzer Y; Tokat Y; Oezcelik A
Cancer Control; 2021; 28():10732748211011960. PubMed ID: 33926242
[TBL] [Abstract][Full Text] [Related]
14. Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful downstaging therapies.
Lei J; Yan L
J Gastrointest Surg; 2012 Nov; 16(11):2120-5. PubMed ID: 22948843
[TBL] [Abstract][Full Text] [Related]
15. Clinical Impact of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma.
Lee SD; Kim SH; Kim SK; Kim YK; Park SJ
Transplantation; 2015 Oct; 99(10):2142-9. PubMed ID: 25905981
[TBL] [Abstract][Full Text] [Related]
16. Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria.
Woo HY; Jang JW; Choi JY; You CR; Jeong SW; Bae SH; Yoon SK; Lee YS; Kim DG
Liver Int; 2008 Sep; 28(8):1120-8. PubMed ID: 18492023
[TBL] [Abstract][Full Text] [Related]
17. Living-donor liver transplantation for hepatocellular carcinoma.
Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
[TBL] [Abstract][Full Text] [Related]
18. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center.
Lee SG; Hwang S; Moon DB; Ahn CS; Kim KH; Sung KB; Ko GY; Park KM; Ha TY; Song GW
Liver Transpl; 2008 Jul; 14(7):935-45. PubMed ID: 18581465
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of the Kyoto criteria as expanded selection criteria for liver transplantation for hepatocellular carcinoma.
Kaido T; Ogawa K; Mori A; Fujimoto Y; Ito T; Tomiyama K; Takada Y; Uemoto S
Surgery; 2013 Nov; 154(5):1053-60. PubMed ID: 24074704
[TBL] [Abstract][Full Text] [Related]
20. Survival differences between Milan criteria after down-staging and De novo Milan in living donor liver transplantation for hepatocellular carcinoma.
Ahn CS; Moon DB; Lee SG; Hwang S; Kim KH; Ha TY; Song GW; Jung DH; Park GC; Park YH; Park HW; Jung BH; Kang SH
Hepatogastroenterology; 2014; 61(129):187-91. PubMed ID: 24895818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
